FDA

The first oral treatment designed specifically for COVID-19 has been authorized for use in the US by the FDA. Called Paxlovid, the treatment is recommended for those at high risk of severe COVID-19 and is to be taken within five days of symptom onset.

The first FDA-approved eye drops to treat age-related blurry near vision (presbyopia) has gone on sale in the US, offering a potential alternative to reading glasses for the estimated 128 million Americans affected by this common condition.

Ahead of a FDA advisory panel meeting, drugmaker Merck has revealed final analysis data from a Phase 3 trial testing its oral antiviral pill against COVID-19. The new data reveals the treatment is significantly less effective than early indications.

A new study is reporting more than one in three patients trialing the recently approved Alzheimer’s drug aducanumab experienced brain swelling side effects. The data is the first from the drug’s Phase 3 trials to be peer-reviewed and published.

US regulators have authorized a 3rd COVID-19 vaccine booster for adults over age 18. The recommendations simplify the health advice and infectious disease expert Anthony Fauci urges boosters for all those who are six months beyond their second dose.

Novavax says its COVID-19 vaccine is finally ready for mass distribution. Amid a flurry of applications being filed, Indonesia is the first to formally grant emergency authorization and the company hopes to file with the US FDA by the end of 2021.

An endorsement by Rochelle Walensky, director of the US CDC, is the final regulatory hurdle to be overcome allowing a special pediatric formulation of Pfizer's mRNA vaccine to be administered to children across the United States.

In a long-awaited decision the FDA has approved "mix and match" COVID-19 vaccine boosters, meaning your third dose does not need to be the same vaccine as your primary course. Boosters are also recommended for all who received the single-dose J&J vaccine.

Researchers on the hunt for a pre-approved medicine that can be repurposed to treat Alzheimer’s disease have found exposure to a common diuretic drug could significantly reduce a person’s risk of developing the disease.

After weeks of regulatory discussions, COVID-19 vaccine boosters are finally rolling out across the US following the final tick of approval from CDC director Rochelle Walensky. The program only applies to those previously administered the Pfizer vaccine.

The FDA has formally approved a booster dose of Pfizer’s COVID-19 vaccine for some populations in the United States. The approval allows a third Pfizer dose for those over the age of 65 and adults over 18 at high-risk of severe disease.

How do rapid antigen COVID-19 tests work? Why did the US government just pledge to buy 280 million of them? And is that even enough to help curb the spread of the virus?